These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8434561)

  • 1. A modern view of atherogenesis.
    Schwartz CJ; Valente AJ; Sprague EA
    Am J Cardiol; 1993 Feb; 71(6):9B-14B. PubMed ID: 8434561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenesis of atherosclerosis: an overview.
    Schwartz CJ; Valente AJ; Sprague EA; Kelley JL; Nerem RM
    Clin Cardiol; 1991 Feb; 14(2 Suppl 1):I1-16. PubMed ID: 2044253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of the atherogenic process.
    Schwartz CJ; Kelley JL; Nerem RM; Sprague EA; Rozek MM; Valente AJ; Edwards EH; Prasad AR; Kerbacher JJ; Logan SA
    Am J Cardiol; 1989 Oct; 64(13):23G-30G. PubMed ID: 2679027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of oxidized low density lipoprotein in atherogenesis.
    Jialal I; Devaraj S
    J Nutr; 1996 Apr; 126(4 Suppl):1053S-7S. PubMed ID: 8642431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase.
    Kaplan M; Aviram M
    Clin Chem Lab Med; 1999 Aug; 37(8):777-87. PubMed ID: 10536926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.
    Quinn MT; Parthasarathy S; Fong LG; Steinberg D
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2995-8. PubMed ID: 3472245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
    Carew TE; Schwenke DC; Steinberg D
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7725-9. PubMed ID: 3478721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages.
    Malden LT; Chait A; Raines EW; Ross R
    J Biol Chem; 1991 Jul; 266(21):13901-7. PubMed ID: 1906887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of oxidized low density lipoprotein in the pathogenesis of atherosclerosis.
    Kita T; Ishii K; Yokode M; Kume N; Nagano Y; Arai H; Kawai C
    Eur Heart J; 1990 Aug; 11 Suppl E():122-7. PubMed ID: 2226520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of biologically modified low-density lipoprotein in atherosclerosis.
    Carew TE
    Am J Cardiol; 1989 Oct; 64(13):18G-22G. PubMed ID: 2679026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New findings on the pathogenesis of atherosclerosis].
    Fialová L
    Cesk Fysiol; 1995 Jun; 44(2):92-101. PubMed ID: 8665598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals.
    Takahashi K; Takeya M; Sakashita N
    Med Electron Microsc; 2002 Dec; 35(4):179-203. PubMed ID: 12658354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the pathogenesis of atherosclerosis.
    Wissler RW
    Am J Med; 1991 Jul; 91(1B):3S-9S. PubMed ID: 1867233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis.
    Rosenfeld ME; Palinski W; Ylä-Herttuala S; Carew TE
    Toxicol Pathol; 1990; 18(4 Pt 1):560-71. PubMed ID: 2091235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
    Aviram M
    Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease and nutrient antioxidants: role of low-density lipoprotein oxidation.
    Frei B
    Crit Rev Food Sci Nutr; 1995 Jan; 35(1-2):83-98. PubMed ID: 7748483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.
    Napoli C; D'Armiento FP; Mancini FP; Postiglione A; Witztum JL; Palumbo G; Palinski W
    J Clin Invest; 1997 Dec; 100(11):2680-90. PubMed ID: 9389731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo inhibition of foam cell development by probucol in Watanabe rabbits.
    Steinberg D; Parthasarathy S; Carew TE
    Am J Cardiol; 1988 Jul; 62(3):6B-12B. PubMed ID: 3394654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis.
    Parthasarathy S; Steinberg D; Witztum JL
    Annu Rev Med; 1992; 43():219-25. PubMed ID: 1580586
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.